partnering

News

Lab-in-a-loop specialist Relation attracts Novartis alliance

UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.

R&D

pharmaphorum podcast Episode 224, Sigma Mostafa, KBI Biopharma

CDMOs: Their crucial role and how to select one, with Sigma ...

Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.

News

Merck partners Valo on $3bn, AI-based Parkinson's project

Merck has teamed up with Valo Health on a project to apply AI to the discovery of novel drug targets and drugs for Parkinson's.

News

AbbVie exits alliance with Alphabet biotech Calico; report

Reports are emerging that a multibillion-dollar partnership between AbbVie and Calico has come to an end after more than a decade.

News

GSK strikes again, adding COPD candidate in $745m deal

In its second pipeline-expanding deal in 24 hours, GSK has licensed rights to a drug for COPD from US biotech Empirico for $85m upfront.

News

As Blenrep returns, GSK adds another ADC to cancer pipeline

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.

Lab-in-a-loop specialist Relation attracts Novartis alliance

CDMOs: Their crucial role and how to select one, with Sigma ...

Merck partners Valo on $3bn, AI-based Parkinson's project

AbbVie exits alliance with Alphabet biotech Calico; report

GSK strikes again, adding COPD candidate in $745m deal

As Blenrep returns, GSK adds another ADC to cancer pipeline

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

partnering

Editor's Picks